Rock Springs Capital Management LP - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$71,780,607
-0.9%
1,419,150
-8.5%
1.92%
+11.6%
Q2 2023$72,404,704
+30.1%
1,550,754
+6.6%
1.72%
+29.7%
Q1 2023$55,639,758
-27.5%
1,454,254
+3.8%
1.33%
-28.1%
Q4 2022$76,755,839
+64.5%
1,400,654
+2.2%
1.85%
+53.3%
Q3 2022$46,648,000
+626.5%
1,369,973
+101.6%
1.20%
+544.4%
Q2 2022$6,421,000
-28.8%
679,514
+7.0%
0.19%
-17.6%
Q1 2022$9,014,000
-27.4%
635,214
+8.2%
0.23%
-20.9%
Q4 2021$12,417,000
-2.3%
587,101
+3.2%
0.29%
+7.5%
Q3 2021$12,710,000
-3.1%
568,701
+7.6%
0.27%
+3.1%
Q2 2021$13,115,000
-13.3%
528,601
+1.4%
0.26%
-21.5%
Q1 2021$15,119,000
+13.7%
521,171
+1.1%
0.33%
+17.0%
Q4 2020$13,297,000
+2.1%
515,371
+21.8%
0.28%
-14.5%
Q3 2020$13,025,000
+115.1%
423,040
+74.1%
0.33%
+98.8%
Q2 2020$6,055,000
+26.9%
242,985
+8.0%
0.17%
-15.7%
Q1 2020$4,770,000
-4.5%
225,0000.0%0.20%
+24.7%
Q4 2019$4,994,000
-2.4%
225,0000.0%0.16%
-22.5%
Q3 2019$5,119,000
+18.8%
225,0000.0%0.20%
+30.8%
Q2 2019$4,309,000225,0000.16%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders